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Abstract
The spliceosome machinery is composed of several proteins and multiple small RNA molecules 
that are involved in gene regulation through the removal of introns from pre-mRNAs in order to 
assemble exon-based mRNA containing protein-coding sequences. Splice-switching oligo-
nucleotides (SSOs) are genetic control elements that can be used to specifically control the 
expression of genes through correction of aberrant splicing pathways. A current limitation with 
SSO methodologies is the inability to achieve conditional control of their function paired with 
high spatial and temporal resolution. We addressed this limitation through site-specific installation 
of light-removable nucleobase-caging groups as well as photocleavable backbone linkers into 
synthetic SSOs. This enables optochemical OFF → ON and ON → OFF switching of their 
activity and thus precise control of alternative splicing. The use of light as a regulatory element 
allows for tight spatial and temporal control of splice switching in mammalian cells and animals.
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Alternative splicing (AS) plays a large role in the regulation of gene expression,1 as the 
spliceosome is responsible for processing of pre-mRNA into coding sequence by eliminating 
introns and assembling the correct exons.2 The splicing of pre-mRNA in humans was 
documented in the mid 1980s,3 and the field has dramatically expanded since. It has been 
estimated that 95% of all human genes show AS pathways, highlighting the importance of 
spliceosome activity in RNA regulation.4–6 Additionally, up to 50% of mutations associated 
with genetic disorders result in altered pre-mRNA splicing pathways,7 linking aberrant 
mRNA splicing to a wide variety of disease states, including cystic fibrosis and Duchenne 
muscular dystrophy.8 Splice-switching oligonucleotides (SSOs) act by hybridizing to the 
pre-mRNA and blocking splice sites in a sequence-specific manner, which prevents 
interaction with components of the spliceosome such that splicing pathways are altered. 
SSOs are commonly used tools to control gene expression via alternative mRNA splicing 
pathways through the removal of aberrant introns or exons as well as exon retention or 
skipping.9 For example, the coding region of a protein can be interrupted via a mutant intron 
gene (Supporting Information Figure 1A). Through AS pathways, the aberrant sequences 
can be blocked with SSOs, allowing for corrected exon splicing and resulting in the 
expression of a functional gene product (Supporting Information Figure 1B). Besides 
applications as research tools, SSOs are proposed for use as therapeutic agents to correct 
splice mutations10–12 and have been applied to genetic disorders for the initiation of several 
human clinical trials13–17 because these oligonucleotides are able to restore proper gene 
function in disease states.
However, no conditional control of SSO activity has been reported, and neither temporal nor 
spatial regulation of SSO function and AS has been achieved. The specific timing and 
location of AS play very important roles in many regulatory pathways in cells across the 
animal kingdom, for example, during neuronal cell differentiation in the human brain.18,19 
Similar spatial and temporal activity of AS has been observed in fruit flies,20 mice,21 
zebrafish,22,23 and nematodes,24 demonstrating that distinct AS patterns are responsible for 
many essential biological functions. Methods to accurately perturb the spatial and temporal 
patterns of AS are critical for understanding the complex mechanisms that underlie gene 
regulatory control by the spliceosome.25 However, traditional SSOs are constitutively in an 
ON state, i.e., the splicing pathways are immediately altered and cannot be controlled with 
any spatial and temporal resolution, precluding precise investigation of AS in cells and 
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multicellular organisms. In order to achieve conditional control of alternative splicing, we 
developed optochemical tools based on the introduction of caged nucleobases and 
photocleavable linkers into SSOs.26,27 This approach enabled both optochemical activation 
and deactivation of splicing pathways, leading to efficient two-directional genetic control 
through OFF → ON as well as ON → OFF light switches. These optochemical regulation 
tools provide conditional control of SSO activity with high resolution in cellular and 
embryonic environments, providing spatial and temporal capabilities for dissection of AS 
pathways as well as the general control of gene function.
RESULTS AND DISCUSSION
Before applying our light-controlled SSO approach to a complex biological system, such as 
a developing zebrafish embryo, we first selected the β-globin intron 1 as a proof-of-principle 
target, since it contains an aberrant splice site that contributes to the genetic blood disorder 
β-thalassaemia and that can be corrected with SSOs.28–32 HeLa cells stably expressing an 
enhanced green fluorescent protein (EGFP) gene interrupted with the mutant β-globin intron 
(HeLa:EGFP654)12 were used to analyze the optochemical regulation of SSOs and the 
ability to control AS pathways with light. The EGFP reporter gene contains an altered 
coding region with an aberrant splice site to impair functional fluorescent protein expression 
until it is blocked by a sequence-specific SSO. The activity of control SSOs was analyzed 
using TAMRA-labeled oligonucleotides to track transfection, for both a noncaged SSO and 
a five-base-mismatched oligo (Supporting Information Table 1). EGFP expression was 
observed only in the presence of the positive control SSO (Supporting Information Figure 
2), and no detrimental effect on the SSO-controlled expression of EGFP in the presence of 
UV light was detected, ensuring that the reporter construct itself was not UV responsive 
(Supporting Information Figure 3). In order to optochemically regulate SSO activity, 
oligonucleotides with light-responsive modifications were synthesized containing 2′OMe 
nucleotides and phosphor-othioate linkages, which are highly effective oligonucleotide 
chemistries for cellular applications of SSOs.9,33 First, a nucleobase-caged SSO was 
engineered that contained light-removable protecting groups that inhibit hybridization to the 
complementary pre-mRNA target. A 2′OMe-NPOM-caged uridine phosphoramidite was 
synthesized34 (Supporting Information Figure 4A) and incorporated into the SSO at four 
positions throughout the sequence, as indicated in Supporting Information Table 1, to 
achieve full inhibition of duplex formation. This light-activated SSO (LASSO) was designed 
to be inactive when transfected into cells until briefly exposed to UV light, thus enabling 
efficient OFF → ON photoswitching for aberrant splice correction (Figures 1A,B). The 
LASSO was synthesized using phosphoramidite chemistry, gel extracted to obtain a high-
purity full-length oligomer (Supporting Information Figures 4B and 5), and subsequently 
transfected into the HeLa reporter cell line. In the absence of UV irradiation, no EGFP 
expression was observed, but after a short UV exposure the AS pathway was activated 
through SSO decaging, leading to removal of the mutant intron and recovery of EGFP 
reporter gene expression (Figure 1D). Only cells that were UV-irradiated exhibit splice-
switching activity and EGFP expression. In order to maximize light activation, the 
parameters for UV irradiation and LASSO concentration were further analyzed, revealing a 
200 nM concentration and a 2 min irradiation time as being optimal for light-activated splice 
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correction (Supporting Information Figure 6). Diminished LASSO activation is observed 
with shorter irradiation times. Importantly, no background leakiness of the LASSO before 
irradiation was observed, confirming excellent OFF to ON switching behavior.
As a second approach, a light-cleavable oligonucleotide was synthesized to enable ON → 
OFF photoswitching of gene expression using an ortho-nitrobenzyl (ONB) linker35 
(Supporting Information Figure 4A). The ONB group was incorporated at two locations 
internally within the SSO sequence, as indicated in Supporting Information Table 1, both to 
maintain binding with the target site and to ensure complete cleavage of the full-length 
oligonucleotide through a brief UV exposure. This light-deactivated SSO (LDSSO) was 
designed to be active in the absence of UV irradiation, but it can be deactivated with UV 
light, inducing oligonucleotide cleavage (Figures 2A,B). The successful synthesis and UV-
dependent cleavage of the LDSSO was confirmed by gel analysis prior to cellular 
applications (Supporting Information Figure 4B and 5). Transfection of the LDSSO 
confirmed that the installation of ONB linkers did not interfere with the SSO activity and 
that splice-switching correction for the expression of EGFP occurred in the absence of UV 
exposure (Figure 2D). In contrast, cells that were UV-irradiated showed no EGFP expression 
due to deactivation of splice-switching oligonucleotide as a result of light-induced 
oligonucleotide fragmentation. Importantly, splice correction with the LDSSO was 
completely deactivated through UV irradiation, demonstrating an excellent ON → OFF 
switching behavior of the SSO pathway. Thus, in conjunction with the LASSO described 
above, both optical activation and deactivation of splice-switching pathways are possible.
The effect of optochemical regulation of SSO activity and aberrant intron splicing on EGFP 
expression was then quantified through flow cytometry. Conditions for cell transfection and 
fluorescent cell counting were optimized both for the LASSO and LDSSO (Supporting 
Information Figure 7), followed by analysis of the optical OFF → ON and ON → OFF 
switching with the light-regulated SSOs and comparison to a noncaged positive control 
(Figure 3). The EGFP reporter expression for the LASSO was fully restored, showing nearly 
identical expression levels as that of the control after a 2 min UV irradiation for light-
activation of SSO function. The light-deactivated SSO showed similarly high levels of EGFP 
expression as that of the noncaged SSO in the absence of UV irradiation but greatly reduced 
expression levels after UV exposure. Both SSO light switches exhibited >10-fold changes in 
EGFP expression between the OFF and ON states. These findings are in agreement with the 
observations from cellular micrographs presented in Figures 1 and 2, validating the 
application of photocaged bases and photocleavable linkers for optochemical activation and 
deactivation of aberrant splicing pathways.
The ability to specifically control the location of SSO optochemical regulation through 
localized UV illumination was then investigated. Irradiations for the LASSO were 
performed using irradiation masks as well as microscope optics. When UV irradiation was 
applied in a spatially defined area in conjunction with the light-activated SSO, only the cells 
that were exposed to 365 nm light exhibited EGFP expression through an OFF → ON light 
switch of SSO activity (Figure 4). The time of irradiation was decreased from 2 min to 30 s 
for localized irradiations because these were performed through focusing microscope optics 
using a Xe/Hg lamp. The tight spatial control conferred with this method can potentially be 
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used to analyze splice switching and aberrant intron correction in small subsets of cellular 
populations as well as within defined locations in multicellular organisms.
In order to translate our methodology for the optical regulation of splice-switching from cell 
culture experiments to multicellular organisms, we targeted an endogenous gene in zebrafish 
to demonstrate conditional control of RNA splicing. The zebrafish embryo was selected as a 
model system because it has been shown that UV-A exposure does not affect zebrafish 
embryonic development, hatch rate, mortality, or global gene expression,36 making this 
translucent and ex utero developing animal highly suited for photoactivation studies with 
micro-injected caged oligonucleotides.37,38 We designed a light-activated splice-switching 
oligonucleotide targeting sox31 (also known as sox19b), a member of the B1 Sox gene 
family that is responsible for many critical processes during zebrafish development, both 
before and after the midblastula transition (MBT).39–41 During the blastulation stage, sox31 
is expressed throughout the blastoderm, where it then assists in epiboly formation during the 
gastrulation stage.42 Splice variants of sox31 have been previously generated with 
morpholino oligonucleotides (MO) targeting cryptic splice sites in sox31.43 Alternative 
splicing-based inhibition of sox31 resulted in normal development during the first 3 hpf, 
followed by arrested embryonic development and loss of epiboly formation for zebrafish that 
failed to undergo gastrulation. Although these findings were made with MOs, there is 
precedence for the use of 2′OMe-modified oligonucleotides as antisense agents in 
zebrafish.44 As such, a 2′OMe sox31 LASSO was synthesized with NPOM-caged uridine 
residues incorporated at four positions throughout the sequence, as indicated in Supporting 
Information Table 1, and purified for injection into zebrafish embryos (Supporting 
Information Figure 4B). The sox31 LASSO was designed to be inactive in the absence of 
UV exposure, allowing for correct RNA splicing and functional protein production (Figure 
5A). However, after a brief UV exposure, the sox31 LASSO will be activated through 
photolysis of the nucleobase caging groups and will bind the RNA target site, initiating AS 
and production of a nonfunctional interrupted RNA (Figure 5B). To this end, embryos were 
injected with the oligonucleotides (5 ng) and either irradiated (365 nm, 2 min) or kept in the 
dark. At 8 h postfertilization (hpf), the embryos were imaged during the gastrulation stage 
when ~75% epiboly formation is expected (Figure 5C), and the frequency of embryos 
exhibiting epiboly defects was determined (Figure 5D). The noninjected embryos were not 
affected by UV exposure, as no significant changes in development were observed. Injection 
with the noncaged positive control sox31 SSO showed developmental arrest and high 
frequency of the no epiboly phenotype. A negative control scrambled 2′OMe 
oligonucleotide shows low levels of developmental arrest, slightly above those observed for 
noninjected embryos. The sox31 LASSO showed normal epiboly formation and 
development through gastrulation for the injected embryos in the absence of UV irradiation, 
similar to the negative control. However, activation of the LASSO with UV irradiation 
inhibited sox31 expression and induced the no epiboly phenotype to the same high levels as 
that observed for injection of the noncaged control. Thus, the conditional control of splice 
switching of an endogenous gene was successfully demonstrated in a living animal. 
Additionally, UV exposures at different time points from 1 to 7 hpf were performed to 
determine temporal requirements for the activity of sox31 during early embryonic 
development. Only embryos irradiated after 4 hpf (after the MBT) showed a distinct 
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decrease in epiboly defects (Supporting Information Figure 8), supporting functional sox31 
as a requirement for epiboly formation.43 Thus, the sox31 LASSO enabled OFF → ON 
photoswitching of a dominant negative splice variant, thereby inhibiting sox31 and other 
SoxB1 genes in the developing zebrafish embryo.
SUMMARY
Alternative splicing (AS) is an important factor in the regulation of gene expression, 
responsible for the processing of pre-mRNA in many organisms. Misregulation of the 
spliceosome resulting in aberrant splicing is associated with a wide range of human genetic 
disorders, and distinct changes in endogenous alternative splicing can lead to gene 
expression patterns that are tightly regulated in many biological pathways. Splice-switching 
oligos (SSOs) provide a method to investigate AS and control splicing pathways through 
hybridization with the pre-mRNA, which blocks splice sites and prevents interaction with 
components of the spliceosome, thus modulating gene expression and protein function. In 
order to address the lack of tools to conditionally regulate SSO function with spatial and 
temporal resolution, we developed a method to regulate AS pathways with light as an 
external control element. The installation of caged nucleobases in synthetic SSOs enabled 
optochemical activation of splice switching and alternative expression pathways in live cells 
and animals. Light-triggered deactivation of splice switching was demonstrated through the 
installation of photocleavable linkers into the oligonucleotide backbone. The NPOM-caged 
nucleobases and ONB-linker groups site-specifically introduced into SSOs were used to 
develop both OFF → ON and ON → OFF light switches for gene splicing, with excellent 
switching behavior and no detectable background activity before light exposure. These 
findings are supported by cellular micrographs as well as florescent cell quantification using 
an EGFP reporter system in human cells. In addition, spatial control of SSO function in a 
cellular monolayer was achieved through localized UV exposure, showing distinct splice-
switch regulation and activation of the caged SSO in a subset of cells. The conditional 
control of splice switching was demonstrated with the correction of a mutant intron, but it 
could be readily applied to other mechanisms of AS, such as mutant exon removal or 
processing of genes that contain multiple splice variants. To this end, we applied the 
developed methodology to the regulation of mRNA processing for an endogenous gene in a 
living organism, by targeting sox31 splicing in zebrafish embryos. The induction of 
developmental arrest through the inhibition of epiboly formation during zebrafish 
gastrulation was conditionally controlled with injection of a sox31 light-activated SSO, 
successfully demonstrating temporal regulation of AS pathways in a complex animal model. 
By conveying optochemical regulation to SSOs, we have added a new level of precision for 
conditional control over these gene regulatory tools and potential therapeutic reagents. The 
developed methodology will aid in the investigation of spatial and temporal mechanisms 
underlying spliceosome correction, aberrant splice switching, and their function in cells as 
well as multicellular organisms.
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The noncaged and negative control SSOs were gifted from Rudolph Juliano. The negative 
control scramble 2′OMe oligonucleotide was purchased from Ambion. DNA synthesis of 
modified oligonucleotides was performed using standard β-cyanoethyl phosphoramidite 
chemistry, with 2′OMe bases and phosphorothioate linkages on an Applied Biosystems 
model 394 automated DNA/RNA synthesizer at a 0.2 mM scale with solid-phase supports. 
All commercial reagents were obtained from Glen Research. The 2′OMe 6-
nitropiperonyloxymethyl (NPOM)-caged uridine34 and the ortho-nitrobenzyl (ONB) linker35 
phosphoramidites were synthesized as previously described and dissolved in anhydrous 
acetonitrile to a final concentration of 0.05 M. Standard synthesis cycles provided by 
Applied Biosystems were used with 10 min coupling times for all 2′OMe bases. The 
sulfurization step was performed using the Beaucage sulfurizing reagent (3H-1,2-
benzodithiole-3-one-1,1-dioxide) at 0.05 M in acetonitrile for 15 min. Oligonucleotides were 
eluted from the solid-phase supports with 1 mL of ammonium hydroxide methylamine 
(AMA, 1:1) and deprotected at 65 °C for 2 h. The full-length caged oligonucleotides were 
purified with Nap-10 columns (GE Healthcare) followed by PAGE gel band excision and 
elution into PBS buffer, pH 7.4. Electrospray ionization mass spectrometry (ESI-MS) was 
performed by Novatia (Newtown, PA).
Mammalian Cell Culture
HeLa:EGFP654 cells were grown in 10 cm dishes with DMEM growth media supplemented 
with 10% FBS and 2% penicillin/streptomycin at 37 °C in 5% CO2. The cell line was 
passaged when confluence reached >90% at a 1:10 dilution of approximately 1 × 106 cells 
into a new 10 cm plate containing 10 mL of growth media.
Cellular Transfection of SSOs
HeLa:EGFP654 cells were seeded at ~10 000 cells per well into black clear bottom 96-well 
plates (BD Falcon) and incubated overnight in DMEM growth media supplemented with 
10% FBS and 2% penicillin/streptomycin at 37 °C in 5% CO2. Transfections were 
performed with 50–200 nM of each SSO using 1 μL of X-tremeGENE siRNA reagent 
(Roche) in 200 μL of Opti-Mem (Invitrogen) at 37 °C for 4 h. After 4 h, the Opti-Mem 
transfection mixtures were removed from the cells and replaced with DMEM growth media.
Optochemical Regulation of SSOs
Cellular irradiations were performed with a 365 nm UV transilluminator (6.3 mW/cm2) for 
30 s to 2 min. Spatially distinct UV irradiations were performed through precut vertical slits 
in tinfoil 96-well plate covers and irradiated for 2 min. Additionally, localized irradiations 
were performed with a Zeiss Observer Z1 microscope (40× objective, NA 0.75 plan-
apochromat; Zeiss) and a DAPI (68 HE) filter (ex: BP377/28) with a partially closed shutter 
to irradiate a specific subset of cells for 30 s.
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Fluorescence Imaging of EGFP
Fluorescent imaging was performed after a 24 h incubation. Media was replaced with clear 
DMEM-high modified growth media (Thermo Scientific) for microscopy imaging. 
Expression of EGFP was observed using a Zeiss Observer Z1 microscope (20× objective, 
NA 0.8 plan-apochromat; Zeiss) and a GFP (38 HE) filter (ex: BP470/40; em: BP525/50). 
The EGFP signal was normalized to a standard setting for fluorescent intensity (black = 300; 
white = 3000; gamma = 0.8) in Zen Pro 2011 imaging software. Fluorescent and brightfield 
merged images are shown with scale bars.
Fluorescent Cell Counting
HeLa:EGFP64 cells12 were seeded at ~100 000 cells per well into 6-well plates (BD Falcon) 
and incubated overnight in DMEM growth media supplemented with 10% FBS and 2% 
penicillin/streptomycin at 37 °C in 5% CO2. Transfections were performed with 50–200 nM 
of each SSO using 5 μL of X-tremeGENE siRNA reagent (Roche) in 1 mL of Opti-Mem 
(Invitrogen) at 37 °C for 4 h, at which point the transfection mixtures were removed from 
the cells and replaced with DMEM growth media. After trans-fection, UV irradiations were 
performed as described above followed by 24 h incubation. Cells were then trypsinized with 
500 μL of TrypLE (Invitrogen), washed, and resuspended in 300 μL of PBS, pH 7.4, for 
fluorescent analysis. Flow cytometry was performed on a FACSCalibur (Becton-Dickinson) 
instrument (488 nm argon laser, 530/50 nm BPF) and analyzed using Cellquest Pro software. 
Cells were gated for EGFP fluorescence (above 102.5 RFUs) and analyzed until 20 000 cells 
had been counted for each condition tested. The frequency of EGFP positive cells (gated/
total) was normalized to the noncaged control SSO. Error bars represent the standard 
deviation of experimental triplicates.
Zebrafish Maintenance and Injections
All zebrafish experiments were performed with the University of Pittsburgh Institutional 
Animal Care and Use Committee approval. The Oregon AB* strain was maintained under 
standard conditions at the University of Pittsburgh School of Medicine in accordance with 
Institutional and Federal guidelines. Embryos from natural matings were obtained and 
microinjected at the 1 to 2 cell stage with 5 ng of the oligonucleotides using a World 
Precision Instruments Pneumatic PicoPump injector. Embryos were then irradiated 
immediately following injection for 2 min with a 365 nm UV transilluminator and incubated 
in the dark at 28 °C for 8 h. Imaging was performed on a Leica MZ16FA stereo fluorescence 
microscope with a 1× objective (NA 0.14) at 60× zoom and collected with a QImaging 
Retiga-EXi Fast 1394 digital camera. Phenotype scores were calculated with embryo counts 
of [(no epiboly/alive) × 100]. For each of the replicates, the data were averaged, and 
standard deviations were calculated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Optochemical regulation of splice switching with the LASSO for an OFF → ON gene 
expression light switch. Schematics for the two RNA splicing pathways (black) and the 
mutant intron (red) are shown. (A) In the absence of irradiation, the LASSO does not bind to 
the target site due to inhibition of base hybridization from the nucleobase caging groups. (B) 
UV decaging of the LASSO enables conditional splice correction of the aberrant mutant 
intron and activation of gene expression. (C) Dark blue boxes represent 2′OMe-NPOM-
caged uridine residues, with the light-removable group indicated in red. (D) HeLa:EGFP654 
cells were transfected with the LASSO, irradiated for 2 min or kept in the dark, and imaged 
for EGFP expression after 24 h. Images of the EGFP channel (left) and the EGFP channel 
merged with a brightfield image (right) are shown. Scale bars indicate 0.2 mm.
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Optochemical regulation of splice switching with the LDSSO for an ON → OFF gene 
expression light switch. Schematics for the two RNA splicing pathways (black) and the 
mutant intron (red) are shown. (A) In the absence of irradiation, the LDSSO binds to the 
target site for aberrant splice correction and activation of gene expression. (B) UV cleavage 
of the LDSSO deactivates splice correction, and gene expression is interrupted by the mutant 
intron. (C) Red circles represent ONB linker residues, with the photo-cleavable group 
indicated in red. (D) HeLa:EGFP654 cells were transfected with the LDSSO, irradiated for 2 
min or kept in the dark, and imaged for EGFP expression after 24 h. Images of the EGFP 
channel (left) and the EGFP channel merged with a brightfield image (right) are shown. 
Scale bars indicate 0.2 mm.
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Flow cytometry quantification of optically regulated splice-switching with LASSO and 
LDSSO. HeLa:EGFP654 cells were transfected with the SSOs, irradiated for 2 min or kept 
in the dark, and analyzed for EGFP expression after 24 h. The gated EGFP positive cells 
were normalized to the noncaged control. Error bars represent standard deviations from 
three independent experiments through counts of 20 000 cells each.
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Spatial control of EGFP expression through optical regulation of splice-switching using the 
LASSO. Localized irradiations were performed using a vertical mask (A) or a partially 
closed microscope shutter (B). Cells were imaged after 24 h. Images of the EGFP channel 
(left) and the EGFP channel merged with a brightfield image (right) are shown. Scale bars 
indicate 0.2 mm.
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Optical regulation of splice switching in living zebrafish embryos. Schematic for the RNA 
splicing (black) and its deactivation by the LASSO. Dark blue boxes represent 2′OMe-
NPOM-caged uridine residues. (A) In the absence of irradiation, the sox31 LASSO does not 
bind to the target site and the sox31 mRNA is correctly spliced, resulting in gene expression. 
(B) UV activation of the sox31 LASSO enables conditional splice blocking of the sox31 
RNA, resulting in inhibition of gene expression. (C) Zebrafish embryos were imaged at 8 
hpf, showing the major phenotype observed from treatment with the light-activated and 
control splice-switching oligonucleotides, both without (top) and with (bottom) UV 
irradiation. Arrows indicate the absence of epiboly formation. (D) Zebrafish embryo scores 
were determined for the frequency of no epiboly formation with and without UV exposure 
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(365 nm, 2 min). Error bars represent standard deviations from three independent 
experiments. N = 18–44.
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